LE CHI NGUYEN: Open Payments
NPI 1184894545 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,745 in 60 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $2,102 · 2025 $1,745
Food & beverage: $1,745
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $387 |
| ABBVIE INC. | 13 | $357 |
| Janssen Biotech, Inc. | 15 | $284 |
| E.R. Squibb & Sons, L.L.C. | 6 | $152 |
| Novartis Pharmaceuticals Corporation | 5 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $121 |
| GlaxoSmithKline, LLC. | 3 | $83 |
| PFIZER INC. | 3 | $70 |
| Genentech USA, Inc. | 1 | $28 |
| TerSera Therapeutics LLC | 1 | $25 |
Products named: TREMFYA, KRYSTEXXA, SKYRIZI, RINVOQ, ORENCIA, TAVNEOS, COSENTYX, BENLYSTA.
Industry payments across CA — which companies pay providers there.
